Drug Profile
Factor VIII - Intas Pharmaceuticals
Alternative Names: Factocel VIIILatest Information Update: 19 Nov 2021
Price :
$50
*
At a glance
- Originator Intas Pharmaceuticals
- Class Antihaemorrhagics; Blood coagulation factors; Recombinant proteins
- Mechanism of Action Blood coagulation factor replacements; Factor X stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Haemophilia
Most Recent Events
- 31 Dec 2008 Launched for Haemophilia in India (Parenteral)